Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Latvia

Olainfarm To Export TB Drug To Kazakhstan

February 2007 | FDI Alert

Latvian firm Olainfarm has been awarded a contract by the government of Kazakhstan to supply LVL974,000 (US$1.8mn) of PASA - sodium salt (aminosalicylic acid), a treatment for tuberculosis (TB). BMI is impressed at this deal as it demonstrates Olainfarm expansionist policy into a country that presents clear opportunities for foreign drugmakers, despite the less than ideal operating conditions. Furthermore, the contract is the largest ever signed by the company and will ensure ongoing financial strength, enabling investment in other, more lucrative TB markets, such as

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries